Filings (90d)
Other insiders active in the same sector
No other insider has filed at Peter F. Lebowitz's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- Roger Adsett - $47.51M in INSM purchases and sales in the last 12 months
- Brian Taylor Slingsby - $46.36M in MLYS purchases and sales in the last 12 months
- Matthew Gline - $46.17M in ROIV purchases and sales in the last 12 months
- Larry Robbins - $46.04M in BFLY purchases and sales in the last 12 months
- R01 Fund LP - $45.65M in SDEV purchases and sales in the last 12 months
- Michael John Kazley - $45.65M in SDEV purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Peter F. Lebowitz?
Peter F. Lebowitz is a corporate insider of BridgeBio Oncology Therapeutics, Inc. (BBOT). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Peter F. Lebowitz last file a Form 4?
The most recent primary Form 4 on record is dated 18 June 2026, one of 2 filings going back to 2026.